non-small cell lung cancer Genecast to Evaluate Liquid Biopsy EGFR Mutation Test in Early-Stage Non-Small Cell Lung Cancer The firm hopes its qPCR-based liquid biopsy test could help identify early-stage NSCLC patients eligible for adjuvant or neoadjuvant anti-EGFR TKI treatment. ASCO Studies Highlight Systemic, Racial Inequities in Lung Cancer Biomarker Testing Premium Researchers used real-world data to identify low NGS testing rates, particularly among Black patients, suggesting many aren't getting precision medical treatment. FDA Approves Amgen's Lumakras for NSCLC Alongside Companion Tests From Guardant Health, Qiagen The approval makes Lumakras the first inhibitor of KRAS, once considered "undruggable," to reach the market for KRAS-mutated NSCLC. FDA Approves Janssen's Rybrevant, Guardant360 CDx for EGFR Exon 20-Mutated NSCLC The agency approved amivantamab for non-small cell lung cancer patients harboring EGFR exon 20 mutations, as detected by Guardant Health's blood-based test. Lucence Launches US Validation Study for Liquid Biopsy in Lung Cancer The study will recruit 200 non-small cell lung cancer patients, comparing results of the company's ctDNA testing to tissue next-generation sequencing. Apr 19, 2021 Biodesix's Proteomic Method for Predicting Immunotherapy Response Advancing Toward Market Premium Apr 19, 2021 Amgen, NeoGenomics Partner to Expand Biomarker Testing Access in NSCLC Mar 2, 2021 Agilent Technologies to Acquire Liquid Biopsy Firm Resolution Bioscience for up to $695M Feb 23, 2021 Lung Cancer Organizations to Study Epidemiologic, Genomic Causes in Young Patients Feb 23, 2021 Biocept, Protean BioDiagnostics Team up to Study EGFR Assay in Lung Cancer Feb 11, 2021 UCLA Researchers Look to Validate Saliva as Sample Type for Lung Cancer Molecular Diagnostics Premium Feb 8, 2021 Sophia Genetics, Spanish Lung Cancer Group Team up to Predict Lung Cancer Treatment Response Jan 27, 2021 Spectrum Solutions, UCLA Partner to Study Saliva-Based Early-Stage Lung Cancer Detection Jan 19, 2021 OncoHost Raises $8 Million in Series B Funding Round Jan 11, 2021 Resolution Bioscience, Mirati Therapeutics Sign Companion Diagnostic Agreement Dec 23, 2020 Amoy Diagnostics, Merck KGaA Partner for Lung Cancer Companion Diagnostic Development in China Dec 17, 2020 Stanford Team Develops Mathematical Model of ctDNA Shedding to Predict Lung Cancer Tumor Size Premium Dec 17, 2020 Merus, Sema4 Partner to Accelerate Enrollment in Zenocutuzumab Trial Dec 15, 2020 Burning Rock Biotech Licenses Oncocyte Lung Cancer Assay Dec 10, 2020 Apis Assay Technologies, Moffitt Cancer Center to Evaluate RNA Biomarkers for Cancer Progression Dec 10, 2020 Lucence Obtains CLIA Certification for Palo Alto Lab Dec 7, 2020 Ceres Nanosciences Hydrogel Technology Shows Promise for Capturing Circulating Tumor DNA Premium Nov 16, 2020 Somatic Mutations in Lung Cancer Patients With HLA Supertype B44 Influence Immunotherapy Response Nov 12, 2020 OncoCyte Posts $555K in Q3 Revenues, Net Loss Rises Oct 29, 2020 Roche EGFR Mutation Test Approved by FDA as Companion Diagnostic for NSCLC Load More Breaking News Enzo Biochem, CLX Health Partner to Support COVID-19 Testing for International Travel Type 1 Diabetes GWAS, Fine-Mapping Leads to New Genetic Loci, Potential Drug Targets LSU Health Sciences Center Wins $2.4M to Lead SARS-CoV-2 Variant Sequencing Program NanoString Technologies, Parker Institute for Cancer Immunotherapy Partner on Cell Therapy Project BGI Americas Collaborating With Champions Oncology on Proteomic Cancer Research Personal Genome Diagnostics Inks Cancer Genomic Profiling Deal with Duke University Health System The Scan Missed Early Cases A retrospective analysis of blood samples suggests early SARS-CoV-2 infections may have been missed in the US, the New York Times reports. Limited Journal Editor Diversity A survey finds low diversity among scientific and medical journal editors, according to The Scientist. How Much of a Threat? Science writes that need for a provision aimed at shoring up genomic data security within a new US bill is being questioned. PNAS Papers on Historic Helicobacter Spread, Brain Development, C. difficile RNAs In PNAS this week: Helicobacter genetic diversity gives insight into human migrations, gene expression patterns of brain development, and more.